- Home
- NBIX vs J Comparison
NBIX vs J Comparison
Compare NBIX & J Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | J |
|---|---|---|
| Founded | 1992 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 17.5B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBIX | J |
|---|---|---|
| Price | $142.31 | $132.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 10 |
| Target Price | ★ $176.19 | $155.90 |
| AVG Volume (30 Days) | 977.3K | ★ 1.5M |
| Earning Date | 02-05-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | ★ 4.19 | 2.38 |
| Revenue | $2,682,700,000.00 | ★ $12,029,783,000.00 |
| Revenue This Year | $23.76 | N/A |
| Revenue Next Year | $18.01 | $6.38 |
| P/E Ratio | ★ $33.80 | $51.31 |
| Revenue Growth | ★ 19.61 | 4.60 |
| 52 Week Low | $84.23 | $106.23 |
| 52 Week High | $160.18 | $168.44 |
Technical Indicators
Market Signals| Indicator | NBIX | J |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 34.63 |
| Support Level | $151.09 | $132.50 |
| Resistance Level | $155.55 | $138.13 |
| Average True Range (ATR) | 4.52 | 3.38 |
| MACD | -1.41 | 0.13 |
| Stochastic Oscillator | 5.75 | 11.02 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $11.5 billion in revenue in fiscal 2024.